Market revenue in 2023 | USD 336.6 million |
Market revenue in 2030 | USD 653.3 million |
Growth rate | 9.9% (CAGR from 2023 to 2030) |
Largest segment | Pharmaceuticals |
Fastest growing segment | Biologics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biologics, Pharmaceuticals, Medicated Feed Additives |
Key market players worldwide | Zoetis Inc Class A, Boehringer Ingelheim, Merck & Co Inc, Elanco Animal Health Inc, Dechra Pharmaceuticals, Ceva Santé Animale, Phibro Animal Health Corp Class A, Virbac SA, Bimeda Ireland, Biogenesis Bago |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary medicine market will help companies and investors design strategic landscapes.
Pharmaceuticals was the largest segment with a revenue share of 67.59% in 2023. Horizon Databook has segmented the South Korea veterinary medicine market based on biologics, pharmaceuticals, medicated feed additives covering the revenue growth of each sub-segment from 2018 to 2030.
South Korea veterinary medicine market is anticipated to grow due to rising incidence of disease outbreaks and the presence of prominent market players. For instance, in 2021, according to the National Center for Biotechnology Information, African Swine Fever (ASF) is one of the most complex infectious diseases affecting pigs.
Hence, disease outbreaks would require use of veterinary medicines to control them, as this can affect the life of the animals, which is driving growth of the market within the country. Moreover, some of the market players, such as EASY BIO, Inc., BIONOTE., and Harim Group., are headquartered in South Korea and are taking up various strategic initiatives related to veterinary medicine.
For instance, in 2023, EASY BIO and Opti pharma signed a collaborative agreement to expand the exports of bacteriophage-based feed additives. Functional feed additives with bacteriophages are alternatives for antibiotic resistance, which is a global problem; hence, such initiatives are expected to drive market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea veterinary medicine market , including forecasts for subscribers. This country databook contains high-level insights into South Korea veterinary medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account